Latest Tuberculosis treatment Stories
Healthcare workers in South Africa are at a significantly increased risk of developing drug-resistant tuberculosis, or XDR-TB, in a trend which threatens to further exacerbate the already beleaguered healthcare systems in sub-Saharan countries
Countries in the former Soviet Union and many regions of China are facing an epidemic of multi-drug resistant tuberculosis, according to a new report based on data from 90,000 patients in 83 countries.
A 26-year-old pediatric resident potentially exposed hundreds of patients, including babies, to tuberculosis, officials at three Chicago-area hospitals say. The female resident, a doctor-in-training from Northwestern University, was diagnosed with TB this week, said the Chicago Department of Public Health. As of Friday, no one who had been around the woman had been diagnosed with TB and doctors say the risk to patients is minimal, the Chicago Tribune reported Saturday. The three hospitals...
According to a study reported in The Lancet on Saturday, a new antibiotic has passed a key phase in a test of drugs aimed at shortening the time to cure tuberculosis, offering a potential boon in the fight against TB.
British medical scientists say the discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria might lead to new anti-TB drugs. Until now it was thought that M. tuberculosis bacteria in the lungs of TB patients were rapidly multiplying.
The World Health Organization announced Monday in China, more money and better science are urgently needed to rein in new strains of tuberculosis that are tough or nearly impossible to treat.
Danya Presents Findings of Pilot Study at East African Health Conference in Kenya SILVER SPRING, Md., March 23 /PRNewswire/ -- Danya International, Inc.
The U.S. tuberculosis rate fell to an all-time low of 4.2 cases per 100,000 people, or 12,898 new cases, in 2008, federal health officials said.
U.S. researchers said on Thursday that two existing drugs used in combination appear to offer great promise against the most dangerous form of tuberculosis.
A four-month treatment with the drug rifampin is better tolerated for tuberculosis than the nine-month treatment of isoniazid, Canadian researchers said. Dr.
- A trick or prank.